CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

David Cordani

Executive Chair of the Board, Cigna

Search every verified David Cordani interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. On Cigna’s Q4 2024 earnings call, David Cordani addressed the high cost of GLP-1 medications in the U.S., stating that “Americans are paying prices that are multiples higher for GLP1s compared to other countries, even with full pass through of rebates.” He described this as “not acceptable nor sustainable.” Cordani also discussed changes to Cigna’s standard pharmacy benefit products, saying they will “provide patients lower prices at the pharmacy counter” and “fully benefit from our lower net negotiated prices,” including during the deductible phase. Cordani reaffirmed Cigna’s commitment to its long-term growth target of 10 to 14% and said the company does not see a change to its profit model from shifting client preferences regarding rebate retention. He emphasized that Cigna aims to maintain a “stable low single-digit margin” in its book of business.

Recent appearances

Notable quotes

“If I'm serving 125 million people in the United States, and I have 2% of them that have something that's other than a positive result, that's millions of people. Unacceptable. So within 30 days, we converted that to our commitment to better. We made a public declaration. No one told us we had to around five large commitments around easing access to care, expanding support services, improving value, elevating the acco”

“We made a public declaration that we will pay for all costs for Covid care, regardless of your coverage, if you're a customer of ours. We had no idea what it was going to cost. No idea. When we made that call, it was a Saturday morning. It wasn't a business case attached to that. That was guided by our mission and our value statement.”

“If we want to understand the core aspects to why costs have risen, on the demand side we are consuming more services driven by an aging population and an explosion in chronic care—over 50% of Americans are dealing with chronic health situations; on the supply side, new pharmaceuticals are at a higher and higher cost every year.”

“The federal government is the largest single payer of healthcare. The federal government has the ability to ensure that more of those dollars are spent based on value, which will convert more of the healthcare delivery system to an outcome base versus a consumption based.”

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →